t,-The pathophysiological potential of mediator substances in manifestations of secondary brain damage is attracting increased attention. This is particularly true of the excitatory transmitters glutamate and arachidonic acid. Noxious properties of these compounds in central nervous tissue have been demonstrated. The current study was performed to determine whether glutamate and arachidonate are released in brain tissue secondary to focal trauma. For this purpose, a cold injury of exposed cerebral cortex was induced in cats. Marked accumulation of glutamate was observed in interstitially drained edema fluid, reaching 10 to 15 times the level that was assessed in normal cerebrospinal fluid (CSF) prior to trauma. The extracellular release of glutamate was further dramatically enhanced by a critical decrease of the cerebral perfusion pressure due to a malignant increase of intracranial pressure. Under these conditions, glutamate concentrations 1000 to 1500 times normal levels accumulated in vasogenic edema fluid, demonstrating a relationship between the extent of the release of glutamate in damaged brain and the severity of the insult. Although under normal conditions glutamate concentrations in plasma were considerably higher than in the interstitial fluid, the pronounced increase of glutamate in this compartment due to trauma cannot be explained by transport of the compound together with the plasma-like edema from the intravascular space.
I
NVESTIGATION of the role of active biochemical factors mediating secondary brain damage resulting from head injury or cerebral ischemia has enhanced our understanding. The number of substances considered to play a mediator role (for example, in nerve cell damage, blood-brain barrier dysfunction, or derangements of the microcirculation) is impressive. Thus, clear definitions are required for their identification. As a guideline, this laboratory has proposed: 1) that a mediator should induce manifestations of brain damage; 2) that the mediator be released in the damaged parenchyma and in proportion to the extent of injury; and 3) that specific measures that inhibit the function or activation of a mediator should reduce secondary brain damage resulting from trauma or ischemia. 5 So far, few factors have been convincingly shown to meet all three requirements.l~ In former publications from this laboratory, a function of the kallikrein-kinin system Extracellular glutamate and fatty acids in brain edema as a mediator in the formation of vasogenic brain edema was demonstrated based on the above guidelines. 9' 68"1~ The experiments showing the formation of kinins as a result of focal cerebral injury 68 were also utilized to examine whether glutamate and free fatty acids are released into the interstitial fluid in brain tissue rendered edematous by focal freezing of the brain. The results of this study are reported here.
In this study, we had to show an accumulation of glutamic acid in the extracellular space as evidence of its activation or release, since this amino acid is abundantly present in the intracellular compartment under physiological conditions. 18 ' 47 On the other hand, free fatty acid levels (particularly levels of arachidonic acid) are normally low in both the extra-and intracellular space. 12' 6~176 However, due to the high intracellular and low extracellular content of proteins, which by binding may reduce the toxic effects of fatty acids, an extracellular rather than intracellular accumulation might have serious implications.
A pathophysiological role of glutamate as well as free fatty acids (particularly of arachidonic acid) is supported by many studies. Work by Van Harreveld and Fitkova ~~176176 has demonstrated a function of glutamate in brain cell swelling that occurs during spreading depression and, even more important, after interruption of the oxygen and blood supply to the brain. Cerebral administration of the amino acid (for example, by iontophoresis, ventricle perfusion, or in vitro culture) was shown to induce manifestations of brain damage, such as gross tissue necrosis or cytotoxic brain edema. 9' 23' 53' t~ Systemic administration of glutamic acid in newborn animals whose blood-brain barrier was not yet functional resulted in neurodegenerative disorders. 66' 7s' 8' Much effort has been expended to elucidate the molecular mechanisms of formation of cerebral lesions by glutamate. Many studies concern the hippocampal formation where particularly high concentrations of glutamic acid are present in the commissural fibers and Schaffer's collateral fibers. 77 Interactions of the amino acid with specific binding sites (such as the N-methyl-D-aspartate (NMDA) receptor) appear to play a major role in its normal transmitter function as well as its excitotoxic potential, and blocking of these receptors seems to provide protection against neuronal damage in cerebral ischemia, hypoglycemia, or epilepsy. 28,37,71' 72' 74,91,92,115 An excitotoxic function of glutamate can further be concluded from observations on the protection of neurons against ischemia or hypoglycemia by lesioning of their glutamatergic afferences.SZ.~ 16, 117 Evidence of a release of glutamic acid under pathological conditions in vivo is sparse largely due to the technical problem of sampling interstitial fluid (see above). Attempts have been made to study the extracellular release of glutamic acid in cerebral ischemia using microfiber dialysis. ~6"44 To our knowledge, no evidence has yet been obtained as to whether traumatic cerebral lesions, as used in the current experiments, result in an accumulation of glutamate in the extracellular compartment. Furthermore, a relationship between the extracellular release of glutamate and the severity of an insult has not yet been established in cerebral trauma. The current experiments address this important point also.
Many investigations have been conducted on a mediator function of free fatty acids, particularly arachidonic acid. Based on previous observations that purulent granulocytes may induce brain edema, Fishman and coworkers 22' 34 provided evidence for an involvement of polyunsaturated free fatty acids in the process. Release of unsaturated fatty acids has been demonstrated in brain tissue under various pathological conditions. 2'12"14 '97 So far, accumulation of the material has been studied largely in brain tissue samples but not in extracellular fluid. A method of interstitial fluid drain-.'ge introduced by Gazendam, et al., 4~ for analysis of the oncotic pressure and electrolyte concentrations in vasogenic edema fluid was adopted for the current experiments to obtain extracellular fluid for determination of glutamic acid and free fatty acid concentrations. Increased concentrations of the compounds in the extracellular space would provide further evidence for their role as mediator in a particularly important manifestation of secondary brain damage. A preliminary report on these studies has been published elsewhere. TM
Materials and Methods

Protocol
The experiments were conducted on 43 mongrel cats of both sexes, each weighing 2.0 to 3.0 kg. Ketaminexylazine anesthesia and succinylcholine relaxation for mechanical ventilation were induced after premedication with 0.05 mg/kg atropine. The animals were ventilated with O2-enriched room air. Measurements of end-tidal CO2 were obtained continuously, and the acid-base state of the blood was determined at 30-to 60-minute intervals. Arterial and venous catheters were introduced for measurement of arterial blood pressure, for sampling of arterial blood, or for intravenous injections of anesthetic agents or other drugs. Cerebrospinal fluid (CSF) was sampled immediately after induction of anesthesia by suboccipital puncture of the cisterna cerebellomedullaris. These CSF samples were used for the evaluation of normal interstitial concentrations of glutamate and free fatty acids (see below). Normal CSF under steady-state conditions can be considered to represent the composition of interstitial fluid of the brain. ~11
The skull was exposed and a cannula was introduced into the lateral ventricle for continuous monitoring of intracranial pressure (ICP). Two frontal and two occipital silver electrodes were placed on the dura mater for electroencephalographic (EEG) recording at 30-minute intervals. The EEG activity of the brain was then subjected to power-spectrographic analysis. Focal cold injury was administered according to the method ofKlatzo, et al., 56 through an 18-mm diameter opening in the skull over the parieto-occipital cortex made without injury to the dura mater. The cortex was frozen by application of a copper cylinder filled with a mixture of dry ice and acetone at -68~ for 5 minutes. Simultaneously, a 2% Evans blue dye solution was injected (2 ml/kg body weight) in order to visualize spread of edema into the perifocal brain tissue areas.
The skull was then fixed in a stereotaxic frame for implantation of an array of cannulas for draining interstitial edema fluid. 4~ The array included 10 stainless steel No. 17 cannulas, 4 to 13 mm in length, which were placed through the dura mater and the focal lesion into the underlying white matter. The fixed cannulas, with an outer diameter of 0.5 mm, were maintained in this position until termination of the experiment. Thin nylon wicks that had been previously inserted into the cannulas prevented obstruction of the lumen during introduction into the brain. Polyethylene catheters filled with benzene were attached to the distal part of the cannulas with their peripheral end plugged by a steel rod to prevent displacement of the wicks during insertion of the drainage cannula array into the cerebral tissue. The plugs were then removed to allow fluid to enter the draining cannulas and subsequently to run into the polyethylene catheters. Since the edema fluid was labeled with Evans blue dye, its accumulation in the catheters could be recognized as the ascension of a light-blue fluid column displacing the overlying benzene. In an observation period of up to 7 hours, 3 to 6 #l of fluid collected in the polyethylene catheters. Since it was found that only a few catheters in each array collected fluid, a topographical correlation of the interstitial concentrations was not attempted.
Each experiment was divided into two collecting periods: one lasting 140 minutes after trauma, and the second from 140 minutes until termination of the study at 5 or 7 hours after trauma. Cannulas containing traces of blood or tissue were easily detected and discarded. The edema fluid was stored in the sampling catheter at -70~ prior to determination of the glutamate and fatty acid concentrations. Additional measurements were made in normal CSF as well as in plasma samples drawn early (soon after trauma) and late (5 to 7 hours postinjury). Due to the small volume of the edema fluid samples, determination of glutamate and of the free fatty acids required particularly sensitive methods of measurement. edema fluid, and 30 #1 for CSF. A fluorescence spectrophotometer* was employed which allowed detection of concentrations as low as 0.5 to 1.0 nM/sample. Exposure of the specimen for measurement of the nicotinamide-adenine dinucleotide, reduced (NADH)-fluorescence emission was brief to avoid destruction of the fluorescence indicator. Fluorescence was assessed initially to obtain the control value and was measured again after reaching the end-point of the reaction approximately 1 hour later. The specific fluorescence produced by the addition of glutamate dehydrogenase was measured separately for correction.
Glutamate
Free Fatty Acids
Levels of the following fatty acids in the interstitial edema fluid were determined by gas chromatography and compared with their respective concentrations in normal CSF or plasma at various experimental periods: palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linolic acid (C18:2), linolenic acid (C18:3), and arachidonic acid (C20:4). The gas chromatography data were controlled by mass spectrometry.
Lipid extraction from edema fluid, plasma, or CSF was performed by the technique of Dole and Meinertz. 29 A standard solution was prepared consisting of known fatty acid concentrations, 5% albumin, and physiological saline. The fatty acids had a concentration range of 0.05 to 0.20 ug/ml. Pentadecanic acid (C 15:0) was added as an internal standard to all samples prior to lipid extraction to facilitate evaluation of losses of fatty acids during the preparation. The experimental fluids as well as the standard solution were extracted in specially rinsed glassware. Diazomethane (CHEN2) was used for derivatization. Mass spectrometry measurements were made for control levels and for identification of the gas chromatographic peaks obtained at various retention times. The quality and reproducibility of the assay were tested by 10-fold measurements of the standard solution combined with pentadecanic acid. The data were statistically analyzed for normal distribution and for differences between independent samples using Student's t-test; in cases of a non-normal distribution, the U-test as described by Wilcoxon, Mann, and Whitney was used.
Results
Experimental Course
As described above, induction of cold injury of the brain was standardized as to the size of the cooling probe and the time of exposure to it. Nevertheless, different experimental courses could be distinguished, depending on the extent of the evolving intracranial hypertension. The animals were therefore divided into * Fluorescence spectropnotometer, Model PMQ III, manufactured by Carl Zeiss, Oberkochen, Federal Republic of Germany. two groups, those who did and those who did not conform to the following criteria: 68 1) a decrease of the cerebral perfusion pressure (CPP) below 40 mm Hg for 30 minutes or more; 2) a flat EEG recording; and 3) an ischemic pattern of energy metabolism (such as adenosine triphosphate (ATP), phosphocreatine (CrP), and the lactate/pyruvate-concentration ratio) in tissue samples of the contralateral undamaged brain hemisphere.
Approximately 50% of the animals were found to meet the above criteria, indicating the development of secondary cerebral ischemia. Since disturbances of cerebral blood flow represent a serious complication and a major determinant of a poor outcome in severe head injury, 43 the group of animals with an ischemic course due to severely elevated ICP was included in the study. Thus, the experimental objective of the study (assessment of a release of glutamate and free fatty acids) could be expanded by considering this clinically important complication. Besides, inclusion of this group let us examine whether the release of these factors occurred in proportion to the severity of the lesion.
The CPP, ICP, and energy charge potential are shown in Fig of ICP and not from a decrease of the arterial blood pressure, which remained remarkably stable throughout the experiments.
An impairment of cerebral energy metabolism was reflected by the significant decrease of the energy charge potential to approximately 0.5 in animals with additional ischemia. However, a lower than normal value 1~176 was also found in the experimental group without additional cerebral ischemia (nonischemia group vs. ischemia group: p < 0.001; Fig. 1 ). The ICP was increased in the nonischemia group during the last 60 minutes of the experiment, reaching a mean level of 40 m m Hg. This may explain the somewhat lowered energy charge potential of some brain tissue samples. The EEG activity supported the formal distinction between both experimental groups. During the last 30 to 60 minutes of the experiment, the animals with additional cerebral ischemia exhibited delta waves. The EEG finally became isoelectric. The other group of animals, in which the CPP never fell below the lower threshold of the autoregulation range, had alpha and beta EEG frequencies throughout the experiment; however, their pattern of cerebral energy metabolism (particularly CrP and lactic acid levels and the adenosine diphosphate (ADP)/ ATP concentration ratios) also indicated some impairment of cerebral perfusion.
Glutamate Levels in Normal CSF, Plasma, and Vasogenic Edema Fluid
The glutamate concentrations in edema fluid, plasma, and normal CSF studied at various periods in the animals with and without ischemia are summarized in Fig. 2 . The glutamate concentrations found in normal CSF obtained prior to trauma are shown separately as a control for the interstitial fluid content, and revealed that both the nonischemia and ischemia groups had comparable control conditions. The data are in good agreement with concentrations found in normal human CSF or in rats. 33 ' 48' 54' 55"64' 86' 87 The glutamate concentrations in the intravascular compartment (plasma) had a mean value of 90 to 125 uM, independent of the sampling period and of whether or not cerebral ischemia developed. All studies comparing glutamate levels in CSF and plasma find remarkable differences between both samples. 48'55'64'86'87 Thus, influx of vasogenic edema into the cerebral parenchyma should already raise extracellular concentrations.
Notwithstanding the comparatively high intravascular glutamate concentration, the glutamate levels found in the edema fluid of the animals without additional cerebral ischemia were even higher: approximately 10 to 20 times the normal CSF level, or two to three times the corresponding plasma concentrations (Fig. 2) . Glutamate concentrations of 250 to 320 #M were accumulating in the edematous interstitial space irrespective of the period of sampling. The higher interstitial concentrations compared with the plasma level cannot be explained by transport of glutamate from the vascular
FIG. 2. Ilustration showing glutamate concentrations
(mean _ standard error of the mean) in cerebrospinal fluid (CSF) obtained as baseline measurements prior to cold injury in interstitially drained edema fluid, and in plasma samples obtained before trauma (Plasma l) and after trauma at the end of the experiments (Plasma 2). The subgroups with and without additional cerebral ischemia are shown separately. Edema Fluid 1 was collected within 140 minutes after administration of the focal lesion, whereas Edema Fluid 2 was collected during the remaining part of the experiment. Glutamate concentrations in edema fluid collected from animals without additional ischemia were increased about 10 to 20 times above the normal concentration in CSF. Additional ischemia led to a further rise to approximately 100 to 150 times the normal extracellular concentrations, while progression of edema with time did not further increase extracellular glutamate concentrations in either group. The cerebral lesion or the development of additional cerebral ischemia had no influence on glutamate concentrations in plasma. The markedly higher levels in edema fluid suggest that accumulation of the amino acid had resulted from a release by the cerebral parenchyma, rather than from transport together with vasogenic fluid from the intravascular compartment. compartment into the parenchyma, but would require additional release from the cells of the edematous brain. Analyses of the individual data, however, indicate that glutamate was not always released in the animals without additional ischemia. The glutamate concentrations in edema fluid ranged from 12 to 1263 uM.
The effect of additional cerebral ischemia on the release of glutamate is also seen in Fig. 2 . With ischemia, glutamate concentrations in the edema fluid were further dramatically increased compared to normal CSF levels and also to levels in edema fluid collected in experiments without ischemia. Ischemia raised mean glutamate concentrations to 1050.7 _+ 210.4 uM in edema fluid collected in the first sampling period and to 732.8 _+ 289.5 uM in edema fluid collected in the second sampling period. This is approximately 100 A. Baethmann, et aL times the level found in normal CSF. On the other hand, glutamate concentrations in plasma obtained at both times remained largely unaffected by the development of ischemia. The high glutamate concentration in edema fluid compared to the low level in plasma again reveals that the extracellular accumulation of the amino acid must have resulted from a cellular release in the brain. Independence of the glutamate levels in edema fluid from concurrent plasma concentrations is supported by a regression analysis between concentrations in both compartments, yielding a correlation coefficient (r) of only -0.16 (p = not significant).
Taken together, assessment of glutamate levels in vasogenic edema fluid obtained by interstitial fluid drainage provides evidence of a cerebral release of the neurotoxic compound under conditions relating to severe head injury. Accumulation of glutamate in the extracellular compartment cannot be attributed to a mere transport of the agent together with vasogenic edema fluid from the intravascular compartment. This is ruled out by the glutamate concentrations found in the interstitial compartment, which exceeded those in plasma by many times. As in other experimental observations, t6'44 the extracellular accumulation of glutamate was markedly enhanced by impairment of the cerebral blood flow.
Free Fatty Acid Concentrations
Free fatty acid concentrations were assessed in interstitially drained edema fluid and in plasma to examine the release of the agents in these compartments. As seen in Fig. 3 , cold injury in animals without additional cerebral ischemia did not increase the concentration of fatty acids in plasma samples: the concentrations obtained prior to and after t r a u m a were quite similar. On the other hand, in animals with additional cerebral ischemia from a malignant increase of ICP, some fatty acids were significantly increased in the plasma compartment. This might be attributed to the evolving disturbances of cerebral blood flow rather than to the cerebral lesion itself. Since an increase of free fatty acids in plasma is relatively easy to assess, the phenomenon might be clinically useful as an index of ischemic brain damage.
Several of the fatty acids studied under control conditions in CSF obtained prior to trauma were too low to measure (Fig. 3) . Extrapolating this finding to cerebral parenchyma may indicate that these lipids (linolenic and arachidonic acid in particular) are practically absent in the extracellular compartment under physiological conditions. In Fig. 4 , the fatty acid concentrations in normal CSF are compared with those in plasma and edema fluid from animals with and without additional cerebral ischemia. Almost all fatty acids were significantly higher in edema fluid than in CSF obtained before trauma.
In contrast to the findings for glutamate levels, however, fatty acid concentrations in edema fluid were However, this m a y not exclude the chance that a fraction originated from the intravascular compartment, as supported by a regression analysis between the edema and plasma concentrations (see Fig. 5 ). In a certain number of experiments, a correlation coefficient of r = 0.59 (p < 0.01) was found, suggesting some dependence of the arachidonic acid concentrations in edema fluid on the concurrent plasma levels. On the other hand, animals with arachidonic acid levels in plasma too low to measure had considerable concentrations in edema fluid (Fig. 5) . The findings in this subgroup are, therefore, indicative of an activation of lipolysis in the damaged brain as the sole source of the arachidonic acid increase in interstitial edema fluid. These animals were not included in the regression analysis of Fig. 5 . Unlike glutamate, accumulation of arachidonic acid in edema fluid seemed to have occurred independently of the experimental course. In both types of experiments, arachidonic acid was found to accumulate to a similar degree.
A. Baethmann, et al. Data for animals with additional ischemia are shown in the upper panel and for those without ischemia in the lower panel. No significant concentration differences in edema fluid were found between these experimental groups. Interstitial vasogenic edema fluid had significantly higher fatty acid concentrations than normal CSF obtained prior to trauma. Some fatty acids, such as arachidonic acid (C20:4), were too low to measure in normal CSF. Arachidonic acid in edema fluid exceeded the corresponding plasma level by a factor of two. This indicates that accumulation of the fatty acid in interstitial edema fluid had resulted from cerebral release, rather than from transport through the breached blood-brain barrier. On the other side, accumulation of the other fatty acids in edema fluid might be attributed to uptake from the intravascular compartment into the cerebral parenchyma together with vasogenic edema, n.m. = not measurable.
Summary of Results
The findings of this study demonstrate that a focal cerebral lesion causing formation of vasogenic brain edema is associated with a considerable increase in free fatty acid concentrations in the extracellular compartment of the edematous tissue. However, only in the case of arachidonic acid could accumulation be attributed to an activation of lipolysis in the damaged brain itself, while transport with the vasogenic edema fluid from the intravascular space probably caused the increase of the other fatty acids. It is of interest that cold injury in association with cerebral ischemia raised fatty acid concentrations in the plasma compartment.
Discussion
Mayer and Westbrook 7~ wrote "... in a sense, the brain is loaded with the seeds of its own destruction." The present investigations pertain to the mechanisms of secondary brain damage after head injury. Although the distinction between primary and secondary manifestations of brain damage from acute cerebral lesions is not new, its clinical significance is still important. 7 It might be assumed that progress has been made in the prevention of secondary brain damage by more rapid and effective administration of emergency care in the prehospital phase. 49' 57' 96 Nevertheless, secondary processes still seem to play a predominant role in the outcome of patients with severe head injury or cerebral ischemia. One of the underlying reasons is our limited understanding of the mechanisms causing secondary brain damage. A more profound insight into the complex processes is mandatory in the search for better forms of treatment that will interfere more specifically with the diverse pathological mechanisms.
The deleterious role of active mediator substances has received increasing attention from clinical and experimental research. 5' 8"2~176 Previous studies in 
Glutamic Acid
The findings of the present study add significant evidence for a role of glutamate and of free fatty acids (arachidonic acid in particular) in brain damage. Based on the present experimental observations, release of glutamate and of arachidonic acid might be extrapolated for corresponding clinical conditions such as cerebral contusion from head injury with secondary ischemia. Such a course would conceivably enhance the severity of a cerebral insult. Moreover, the experiments strongly suggest that the extent of glutamate accumulation in the interstitial edema fluid is dependent on the severity of the lesion. As shown in Fig. 2 , development of cerebral ischemia secondary to an increase in ICP led to a further dramatic increase in the release of glutamate into the extracellular space of the edematous parenchyma. Figure 6 shows a regression analysis between the extracellularly accumulating concentrations of glutamate and the fall in CPP utilized as a measure of the impairment of cerebral blood flow. The glutamate concentrations are plotted against the corresponding CPP's, which were averaged during the last 60 minutes of an experiment. Animals with and without additional cerebral ischemia are denoted separately. The analysis shows that the lower the CPP falls the higher are the concentrations of glutamate found in the edema fluid. To our knowledge, such a relationship has not previously been demonstrated in cerebral trauma on a quantitative basis.
Research on a pathophysiological potential of glutamate in central nervous tissue reaches back into the 1950's. Based on studies using brain tissue extracts, Van Harreveld 1~ suggested in 1959 an involvement of the amino acid in cell swelling (such as in ischemia or spreading depression) by increasing Na § permeability of plasma membranes. In the 1960's, Pappius 83 and Ames, et aL, 3 reported swelling of brain tissue slices in a medium containing glutamate. Later, Van Harreveld and Fifkova m7 observed gross destruction of cerebral parenchyma when the amino acid was directly applied to brain cortex. Corresponding findings supporting a neurotoxic function of glutamate were obtained in studies by Lucas and Newhouse 66 and Olney and Sharpe, 7s'st which showed that systemic administration of the amino acid to young or newborn animals whose blood-brain barrier was not yet tight resulted in histological lesions of the retina or brain.
We investigated the potential of glutamate to induce cytotoxic brain edema under in vivo and in vitro conditions. Intraventricular perfusion of the brain with glutamate resulted in cytotoxic brain edema, and suspension of C6-glioma cells in vitro in the presence of the amino acid led to a significant increase in cell size as assessed by flow cytometryfl 'Sa More recently, the role of glutamate as an excitotoxin came into focus in studies of cerebral ischemia and epilepsy. Studies on the interaction with specific receptors mediating physiological as well as pathological responses have enhanced the understanding of molecular mechanisms of nerve cell damage.I~ This area of research has opened up interesting perspectives for specific treatment. 41, 58, 74, 95, 99, 115 The recent availability of refined methods makes it possible to directly investigate the release and accumulation of glutamate in the extracellular compartment of the brain under diverse pathological conditions. Since the method used for assessing the release of a mediator compound is critical for its identification, a brief discussion of current technologies is appropriate. Various methods are utilized, such as measurement in superfusates in vitro or in interstitial fluid drained in vivo, push-pull perfusation, or microdialysis of the brain. 16.40,42,108,114 Studies on the retina in vitro demonstrated that higher than normal glutamate concentrations in a superfusion medium enhance the endogenous release of the amino acid from the intracellular compartment. 1~ This is an important finding, because it suggests that the excessive liberation of glutamate observed in the present experiments in animals with additional ischemia may follow a positive feedback cycle, where initially moderate glutamate concentrations in the extracellular compartment trigger a large response.
The method of interstitial fluid drainage by cerebral implantation of a set of wicked cannulas was introduced by Gazendam, et al., 4~ for analyzing the composition of vasogenic edema fluid. The method was employed to study the colloid osmotic pressure as a determinant of persistence of edema in brain tissue, and to investigate changes in extracellular electrolyte composition. This approach appeared appropriate for the present studies, since by this means extracellular edema fluid is obtained without dilution of its constituents, which occurs with the push-pull perfusion, superfusion, or microdialysis techniques. 42,114 Since interstitial fluid sampling takes place against gravity, collection of fluid by the draining catheters required a higher than atmospheric pressure in the interstitial fluid compartment, which has been described for edematous brain parenchyma. 89 The interstitial pressure of normal brain is probably too low to allow spontaneous drainage of extracellular fluid. Therefore, CSF obtained prior to trauma was used for a control sample. Contamination of the interstitially drained edema fluid with blood or tissue was a rare event and could be easily detected; such specimens were discarded.
A technique to study the composition of extracellular fluid of normal brain in vivo is the implantation of microdialysis fibers with a semipermeable membrane penetrable by substances of low to medium molecular weight (MW) of 5000 to 50,000 dalton. 16' 1~ The dialysis tube is perfused at rates of 0.2 to 10.0 ul/min. 114 The outer diameter of the dialysis fiber is 0.3 mm, which is comparable to that of the 0.5-mm cannulas used for the current experiments (see Materials and Methods). Damage to brain tissue by microdialysis is minor as confirmed by histological examination, 15 assessment of blood-brain barrier function, 1Ol and measurement of regional cerebral blood flow. 17 Perfusion
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of the tube is essential to yield interstitial fluid constituents from normal brain, and the resulting dilution of the actual extracellular composition by perfusion of the dialysis fiber can be accounted for. Extracellular glutamate concentrations found in experiments with microdialysis of normal brain were 2.0 _ 0.2 uM compared to 13.7 to 15.7 tzM in normal CSF obtained in the present studies. 16 Although the dialysis findings might somewhat underestimate actual extracellular levels due to perfusion, it can nevertheless be assumed that extracellular glutamate concentrations in normal brain are somewhat below the corresponding CSF level. 45 Interruptions of cerebral blood flow for 10 minutes in rats led to a threefold increase of aspartate levels and an eightfold increase of glutamate content in the dialysate compared to the preischemic control value. 16 Another study in rabbits revealed a dose-effect relationship between the extracellular accumulation of glutamate and the degree of ischemia. 44 In that study, ischemia for 10 minutes caused approximately a 3.5-fold increase of the extracellular glutamate concentration whereas a 30-minute ischemic period resulted in no less than a 160-fold increase. Simultaneously, an increase of gamma-aminobutyric acid and taurine levels was reported. 44 The 160-fold increase in glutamate is in the order of magnitude that was observed in the current study on focal injury in combination with cerebral ischemia, even though absolute concentrations might vary between both experiments. The extracellular increase of glutamate found in ischemic rabbit brains was reversible within 30 to 60 minutes after termination of ischemia. Normalization of enhanced extracellular glutamate levels was not observed in the present experiments because cerebral ischemia did not subside, as demonstrated by the continuing EEG isoelectricity and low CPP.
Cerebral microdialysis findings on an abnormal accumulation of excitatory transmitters during experimentally induced convulsions are somewhat controversial. In studies using administration of kainic acid, bicuculline, or folate for induction of seizures, glutamate did not accumulate or was only marginally present in the dialysate, whereas the taurine content increased. 62'63'11~ These observations might be difficult to understand since glutamate receptor antagonists act to prevent seizures and seizure-mediated brain damage. 25, 27, 80, 91 Evidence is available in man of an extracellular accumulation of glutamate in the brain under pathological conditions. Engelsen, et al., 33 studied glutamate and aspartate concentrations in patients with impaired cerebral blood flow secondary to an increased ICP. Ventricular glutamate concentrations were increased by 10 to 12 times the level found in control patients with normal-pressure hydrocephalus. In the latter control group, the glutamate and aspartate concentrations in CSF were 2.9 _ 2.2 t~M and 0.2 ___ 0.2 uM, respectively. Conversely, studies in our laboratory of 57 neurosurgical patients with acute or subacute processes, such as subarachnoid hemorrhage, severe head injury, or intracerebral bleeding, could not confirm a significant increase of glutamate in CSF collected by ventricular drainage as compared to a group of control patients with lumbar disc herniation. In intracerebral hemorrhage or severe head injury, however, CSF concentrations of free fatty acids such as arachidonic acid were significantly elevated. 69 An abnormal release of glutamate in edematous brain raises questions concerning its pathological significance. As discussed above, its excitotoxicity might be instrumental in secondary cell swelling in the vicinity of a focal cerebral lesion. 9'23'33"107 Recent evidence indicates that glutamate may exert different mechanisms on nerve and glial cells. Swelling of astrocytic processes due to increased extracellular glutamate levels is likely to result from an active accumulation through highaffinity uptake sites of the cells which subserve their clearance function as a prerequisite for a normal nerve cell activity. 46 ' 47 Uptake of glutamate into glial cells occurs against an extracellular:intracellular concentration ratio of approximately 1:1000. Energy for this reaction is provided by the concurrent influx ofNa + ions along their electrochemical gradient. Actually 1 tool of Na § is reportedly taken up per 1 mol of glutamate. 3~ The price to pay for the glial clearance of glutamate from the extracellular space is a subsequent removal of intracellularly accumulating Na § ions by the active Na + pump. This and metabolism of glutamate to glutamine by the glial glutamine synthetase are ATP-consuming steps. 47 Obviously, borderline conditions such as brain edema with a compromised blood flow are likely to jeopardize the clearance of glutamate from the extracellular compartment due to a failing energy metabolism. Consequently, Na § ions taken up together with the amino acid in the glial cells remain trapped, leading to cell swelling. Moreover, due to an eventual flattening of the extracellular-intracellular Na + gradient utilized as an energy source for the glial glutamate uptake, increasing glutamate concentrations may accumulate sooner or later in the extracellular compartment, with its adverse consequences. This process is markedly enhanced by activation of a positive feedback cycle between the release of glutamate from the cells and increased extracellular concentrations.~~ Other pathological effects can be considered in addition. Higher than normal extracellular glutamate levels are likely to interfere with the activity of synaptic nerve endings. Glutamate increases permeability of cell membranes, particularly of synaptic endings for Na § and Ca ++ ions 3'19'120 through specific interactions with glutamate receptors. 39 '67'72 In addition, administration of glutamate-receptor ligands, such as NMDA, quisqualate, or kainate to spinal cord motor neurons, was found to cause intracellular acidosis. 32 Opening of Ca + § channels, allowing an uncontrollable influx of Ca § ions into cells, might induce a variety of the well-known deleterious mechanisms ultimately causing cell death.
The destruction of selectively vulnerable nerve cells in the hippocampal formation by ischemia or epileptic seizures is considered to occur due to such mechanisms. 98 The emergence of a central role of glutamate in these processes led to the development of specific methods of inhibition. Recent experimental results strongly indicate that inhibition of receptor-mediated glutamate effects might have a clinical potential. 3l'51"58'74"8~ In this context, a protective role of opioid agonists seems to acquire increasing significance. 26'52'79 Taken together, confirmation of a pathological release of glutamate associated with acute cerebral lesions can be considered important, strengthening the concept of the role of the amino acid as mediator of secondary brain damage.
A rachidonic Acid
A potential noxious effect of free fatty acids on brain tissue has been surmised for some years. Experimental studies by Sato, et In the present studies only arachidonic acid was found to be increased in edema fluid as compared to the corresponding plasma concentrations; thus, the discussion is limited to this particularly pertinent compound. Activation of lipolysis seems to be a general, more or less nonspecific response of brain tissue to insults. The velocity of activation of lipotysis in ischemia is impressive. 14"24' 84 Since arachidonic acid is rapidly broken down into the metabolites of the cyclooxygenase and lipoxygenase pathways, the question is frequently raised whether arachidonic acid itself or its metabolities are causally involved in a given pathological mechanism.
Investigations by Kontos, eta/., 59 indicated that inhibition of the cyclo-oxygenase pathway by indomethacin attenuates damage of the cerebrovascular system from administration of arachidonic acid. However, opening of the blood-brain barrier to FITC-dextran (MW 62,000 dalton) by superfusion of the brain with arachidonic acid was not prevented by indomethacin or by BW 755 C, a dual pathway inhibitor blocking lipoxygenase and cyclo-oxygenase. 1~ Notwithstanding the present controversies on the toxicity of arachidonic acid versus its metabolites, formation of arachidonic acid can definitely be considered as a most important step which determines the subsequent release of the cascade metabolites. 36:~8 Therefore, inhibition of release of arachidonic acid should be therapeutically superior to inhibition of the formation of its uncounted metabolites.
Activation of phospholipase A2 and C may constitute a therapeutic target in this context. 2~'61 Phospholipase A2 can be antagonized by corticosteroids which induce an enzyme-inhibiting protein in the tissue. 35 Although evidence is also available supporting a contribution of phospholipase C in the formation of arachidonic acid in pathological brain, 1 means of inhibiting this enzyme are less clear. Since experimental studies on focal cerebral cold injury demonstrate attenuation of the release of arachidonic acid by dexamethasone in the affected hemisphere 88 (but not in the lesion itself84), it may be tentatively assumed that activation of phospholipase A2 is more important for the development of brain edema. 2~ However, evidence that brain edema attenuation by corticosteroids is due to inhibition of the release of arachidonic acid is not specific, since corticosteroids exert a multitude of mechanisms in central nervous tissue. 6 The concept of mediators of secondary brain damage can be viewed as a network system of interacting factors that operate by mutual activation. Accordingly, early selective formation of a single factor, such as arachidonic acid, might trigger further mediator cascades, thereby starting a powerful network system of vasoactive and cytotoxic compounds such as glutamate, kinins, or others. The findings of the present study support this concept. Kinins have been reported to induce the liberation of glutamate or of arachidonic acid; conversely, arachidonic acid has been shown to induce the formation of kinins, setting the stage for a vicious circle of interactive mediator activation. 5~176 Moreover, observations by Westerberg and Wieloch ~3 raise the possibility that an abnormal release of glutamate causes receptor-mediated accumulation of arachidonic acid via the phosphatidylinositol pathway. Mutual enhancement of mediator efficacy of arachidonic acid and glutamate can be further concluded from observations on inhibition of the glutamate uptake of astrocytes and neurons by arachidonic acid, ll9 which suggests an impairment of the extracellular glutamate clearance.
An interacting, mutually amplifying, mediator network may be difficult to inhibit by current therapeutic methods. Such a network might explain the limited efficacy of present methods of treating acute cerebral lesions which are effective only when administered prior to or immediately after the insult. Extracellular release of glutamate and free fatty acids in vasogenic brain edema might be utilized as a test system to analyze the efficacy of new forms of treatment.
80.
